At a glance
ClinicalIndex Comparison RecordN/ACompleted· 35 enrolled
Drug / intervention
Pennsaid +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effects of Pennsaid on Clinical Neuropathic Pain
In Brief
A clinical study evaluating Pennsaid and Placebo (2.3% DMSO solution) for Neuralgia and 3 related conditions. Completed, enrolled 35 participants across 1 site.
Detailed Summary
The purpose of this study is to see if the drug Pennsaid (Diclofenac) can help reduce pain felt by people with chronic nerve pain. The drug will be used 2-4 times each day for 2 weeks. The U.S. Food and Drug Administration (FDA) has approved Pennsaid to treat osteoarthritis (bone pain), but the FDA has not approved Pennsaid to treat neuropathic (nerve) pain. The research study will compare Pennsaid to placebo.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNeuralgia, Postherpetic Neuralgia, Reflex Sympathetic Dystrophy, Complex Regional Pain Syndrome (CRPS)
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartNov 2011
First PostedJan 2012
Primary CompletionMar 2013
Study CompletionJan 2016
TodayJul 2026
First PostedJan 12, 2012
Enrollment StartNov 1, 2011
Primary CompletionMar 1, 2013
Study CompletionJan 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 14.5 years ago
Interventions
Pennsaiddrug
Placebo (2.3% DMSO solution)drug